Your Company

Step of

Address of institution in English

Billing Details

Address

Staff & Training

Select the check box for each contact below if you wish this person to receive notifications for QC due

Head of Department title & full name
Primary contact full name

Additional Contacts

No additional contacts added yet.

Provide the number of theranostics trained personnel as follows

(numeric values only, no decimals, max 20)

Please provide contact details of one board-certified (or local regulation certification) nuclear medicine physician on site

(optional)

Are there challenges in coordinating with oncology/radiotherapy departments?
For EU based only: Is your department compliant with Art. 58 (d) (i) and (ii)

- Art. 58 (d) (i) In radiotherapeutic practices other than standardized therapeutic nuclear medicine practices, a medical physics expert shall be closely involved

- Art. 58 (d) (ii) in standardised therapeutical nuclear medicine practices as well as in radiodiagnostic and interventional radiology practices, involving high doses as referred to in point (c) of Article 61(1), a medical physics expert shall be involved

View Official Journal
Is your staff up to date with local continued education units requirements
Do you run a continuing medical education program
Do you run other internal training programs

Please enter information for all the equipments available at your site

SPECT only gamma camera

SPECT Cameras

SPECT/CT gamma camera

SPECT/CT Cameras

PET/CT

PET/CT Cameras

PET/MR

Is at least one of the PET scanners EARL accredited?
Do you anticipate replacing any of your equipment in the next 5 years?

Do you consider Diagnostic Reference Levels (DRLs) for the diagnostic procedures that you perform in the context of Theranostics?
Are you interested in accrediting your SPECT/CT system via EARL?
Does your radioisotope license allow preparation of radiopharmaceutical kits (beyond administration)?

Is your radiopharmacy GMP-IMP certified for clinical trials?

Do you have a cyclotron?

Do you have in-house radiolabelling facility?
Do you use a 68Ga-generator?
Do you perform immunoPET in the context of theranostics?

If applicable, who is your supplier for?

(optional)

(optional)

(optional)

Select all available radiopharmaceutical therapies at your institution:

No matching therapies found

Selected Therapies

No therapies selected. Please use the multiselect above to select therapies.

(optional)
Has your institution been audited by health/regulatory authorities for radiation safety?
Do you have probe measuring station for uptake measurements?
Do you have radionuclide calibrators at your site?
Do you have dose rate meter?
Do you have activity meter with CE certificate and dedicated QA program in place?
Do you have radiation protection equipment (e.g. contamination monitor)?
Do you have well counter (or equivalent)?
Do you have QM system for radionuclide therapies (therapy SOPs, etc.)?
(optional)
Do you have a waste management system?
(optional)
Can your facility manage carrier-added drug disposal?
Can your facility manage long-term storage of high-activity waste?
Is there a designated bathroom for patients post-therapy?
Do all personnel involved in handling radioactive products receive training in aseptic techniques?
Are there cleaning & disinfection procedures in place for cleaning personnel to follow?
What is the level of involvement of the medical physics expert in theranostic procedures?
Are you performing dosimetry on a routine basis?
Do you have the expertise to perform dosimetry for specific study purposes?
Do you have the capacity to perform dosimetry for specific study purposes?
Do you have quality management system for dosimetry (SOPs, etc.)?
Do you have procedures for backup/storage of dosimetry imaging data?

Which of the following EARL accreditations do you have?

Do you have licensing for performing radioligand therapies?
(optional)

Do you have experience with pediatric theranostics?
Do you have availability of shielded rooms for pediatric radiopharmaceutical therapy infusion?

Provide details for the following therapies (if applicable)

(optional)

(optional)

Release criteria

(optional)

(optional)

Release criteria

(optional)

(optional)

Release criteria

(optional)

(optional)

Release criteria

(optional)
Are you performing clinical trials?

Tick one or more

Do you have the necessary personnel to support clinical trial participation?
(optional)
By completing this EARL Theranostics certification enrolment form, you acknowledge and agree that the European Association of Nuclear Medicine (EANM) and EANM Research GmbH (EARL) may collect, process, and use the submitted data for activities related to quality assurance, certification, statistical evaluation, and potential research in the field of theranostics. The data may be shared internally within EANM and EARL, and with formal partners involved in these activities. Participating sites may be selected for audit to validate the accuracy and completeness of submitted data, in accordance with applicable legal, regulatory, and scientific standards. In such cases, the execution of a non-disclosure agreement (NDA) and a formal audit agreement will be required prior to initiation. By completing and submitting the enrolment form, sites expressly acknowledge EARL’s authority to conduct such audits and affirm their obligation to fully cooperate with the audit process as outlined in the governing agreements.
I agree to the conditions stated above
Agree to have the department head name and email published publicly on the EARL web site
Agree to have the hospital name and the types of theranostics procedure(s) provided a certificate for by EARL, to be published publicly on the EARL web site